The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 3503 -3509
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0802567

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Z.
Right arrow Articles by Chan, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Z.
Right arrow Articles by Chan, S. H.

Polysaccharide-Protein Complex from Lycium barbarum L. Is a Novel Stimulus of Dendritic Cell Immunogenicity1

Zhisong Chen*,{dagger},{ddagger}, Jinhua Lu{dagger}, Nalini Srinivasan*,{dagger}, Benny Kwong Huat Tan{ddagger} and Soh Ha Chan2,*,{dagger}

* World Health Organization Collaborating Centre for Research and Training in Immunology, {dagger} Department of Microbiology and Immunology Programme, and {ddagger} Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Dendritic cell (DC) immunogenicity correlates with its maturation, which can be induced by toxic microbial products such as LPS. In this study, we report that a nontoxic polysaccharide-protein complex isolated from a Chinese medicinal herb, Lycium barbarum (LBP), induces phenotypic and functional maturation of DCs with strong immunogenicity. LBP up-regulated DC expression of CD40, CD80, CD86, and MHC class II molecules; down-regulated DC uptake of Ag; enhanced DC allostimulatory activity; and induced IL-12p40 and p70 production. All of its five fractions were active. LBP developed enhanced Th1 response, and LBP-treated DCs enhanced Th1 and Th2 responses in vitro and in vivo. Our study provides evidence and rationale on using LBP in various clinical conditions to enhance host immunity and suggests LBP as a potent adjuvant for the design of DC-based vaccines.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the World Health Organization Collaborating Centre for Research and Training in Immunology, National University of Singapore Grant R-188-000-001-731 (to S.H.C.).

2 Address correspondence and reprint requests to Dr. Soh Ha Chan, Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597. E-mail address: miccsh{at}nus.edu.sg

3 Abbreviations used in this paper: LBP, Lycium barbarum polysaccharide-protein complex; BMDC, bone marrow-derived dendritic cell; CT, cycle threshold; DC, dendritic cell; LAL, Limulus amebocytes lysate; LBPF, LBP fraction; p.o., by mouth; SFC, spot-forming cell.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.